Literature DB >> 8491251

Lack of association between glucose-6-phosphate dehydrogenase deficiency and dextromethorphan O-demethylation polymorphism.

Y M Irshaid, H F al-Hadidi, N M Rawashdeh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8491251     DOI： 10.1007/BF00271379

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

Review 1.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

2.  A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

Authors:  D A Evans; A Mahgoub; T P Sloan; J R Idle; R L Smith
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

3.  Pharmacogenetics of dextromethorphan O-demethylation in man.

Authors:  A Küpfer; B Schmid; G Pfaff
Journal:  Xenobiotica       Date:  1986-05       Impact factor: 1.908

4.  Simplified phenotyping with dextromethorphan by thin-layer chromatography: application to clinical laboratory screening for deficiencies in oxidative drug metabolism.

Authors:  R J Guttendorf; P J Wedlund; J Blake; S L Chang
Journal:  Ther Drug Monit       Date:  1988       Impact factor: 3.681
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.